Loading...
Login/Register
Welcome
Profile
Log Off
text
title
chapter title
keyword
WHO Home
WHO Health Systems and Services
WHO Medicines
WHO sites
Medicines Documentation home
Search
Titles A-Z
Subjects
Keywords
Series and Periodicals
Publishers
Authors A-Z
Regions
Countries
Index
Sub-collections
Public
sub-collections
Expand Document
|
Expand Chapter
|
Full TOC
|
Printable HTML version
::
Themes & Keywords
·
Keywords
>
equitable access
·
Keywords
>
pharmaceutical sector
·
Keywords
>
public-private roles
·
Keywords
>
rational use
Public-Private Roles in the Pharmaceutical Sector - Implications for Equitable Access and Rational Drug Use - Health Economics and Drugs Series, No. 005
(1997; 115 pages) [
French
] [
Spanish
]
Table of Contents
Authors
Acknowledgements
Abbreviations and Acronyms
Executive summary
1. Public and private roles in the pharmaceutical sector
1.1 Some definitions of public-private roles
1.2 Questions on public-private roles
1.3 The context of change
1.4 Principles for assessing public-private roles
2. Pharmaceutical markets: structure and performance
2.1 Drug financing and distribution systems
2.2 The pharmaceutical market: structures and actors
2.3 Pharmaceutical market failure
3. Essential state responsibilities
3.1 Policy-making
3.2 Drug regulation
3.3 Professional standards
3.4 Access to essential drugs
3.5 Rational drug use
4. The public-private mix in drug markets: a global picture
1
4.1 Production
4.2 National expenditure
4.3 Drug distribution systems
4.4 Household expenditures and sources of drugs
4.5 Summary points
5. Market mechanisms in public drug supply
5.1 Organization of the supply system
5.2 Desirability of using market mechanisms
5.3 Summary points
6. Promoting public health needs through the private sector
6.1 Public health concerns
6.2 Availability (geographical access)
6.3 Making drug prices affordable
6.4 Affordable financing for drugs
6.5 Rational drug use
6.6 Drug quality, safety and efficacy
6.7 Summary points
7. Pharmaceutical production and public-private roles
7.1 Arguments for and against public sector pharmaceutical production
7.2 The government's role in strengthening local production capacity
7.3 Summary points
8. Capacity-building and the process of change
8.1 The nature of capacity and capacity constraints
8.2 Approaches to enhancing capacity
8.3 The process of change
8.4 Summary points
9. Managing public-private roles
9.1 Developing a strategy
9.2 Monitoring and evaluation
9.3 Unanswered questions
9.4 Conclusions
References
Glossary
Back Cover
Authors
Sara Bennett
Jonathan D. Quick
Germán Velásquez
Contacts
|
E-mail scams
|
Employment
|
FAQs
|
Feedback
|
Privacy
|
RSS feeds
© WHO 2013
Last updated: May 3, 2013